LoginSignup
NXG

NexgenRx

Stock
Stock
ISIN: CA65337X1042
Ticker: NXG
CA65337X1042
NXG

Price

Price

Historical dividends and forecast

All dividend data

NexgenRx has so far distributed $0.007402 in 2024. The next dividend will be paid on 04.01.2025

$0.006468

CHART BY

Frequently asked questions

What is NexgenRx's market capitalization?

The market capitalization of NexgenRx is $14.73M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for NexgenRx?

NexgenRx's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0004216. EPS indicates the company's profitability on a per-share basis.

What is NexgenRx's revenue over the trailing twelve months?

Over the trailing twelve months, NexgenRx reported a revenue of $10.96M.

What is the EBITDA for NexgenRx?

NexgenRx's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $962.72K. EBITDA measures the company's overall financial performance.

What is the free cash flow of NexgenRx?

NexgenRx has a free cash flow of $364.58K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of NexgenRx's stock?

The 5-year beta for NexgenRx is 0.35. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does NexgenRx have, and what sector and industry does it belong to?

NexgenRx employs approximately 20 people. It operates in the Financials sector, specifically within the Investment Services industry.

What is the free float of NexgenRx's shares?

The free float of NexgenRx is 44.95M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $14.73M

5Y beta

 0.35

EPS (TTM)

 -$0.0004216

Free Float

 44.95M

Revenue (TTM)

 $10.96M

EBITDA (TTM)

 $962.72K

Free Cashflow (TTM)

 $364.58K

Pricing

52W span
$0.129$0.252

Information

NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys single platform solution simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients. Its NexPension is an advanced pension administration solution designed to help sponsors record and tabulate contributions.

20

Investment Services

Financials

Identifier

ISIN

CA65337X1042

Primary Ticker

NXG
Join the conversation
Sign upLogin